FDA Provides Updates on Ongoing Postmarket Activities for Essure Device

Today, the FDA is providing an update on our ongoing postmarket activities related to Essure , so that patients and health care professionals have up-to-date information. In addition, the FDA is reminding health care providers and facilities that all Essure units should be returned to Bayer by the end of 2019.  Healthcare providers should contact Bayer immediately to arrange return of any devices.

Read More